🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
This will be a randomized, comparative, parallel, clinical study to assess ...
Status
Recruiting
Location
CBCC Global Research Site:005
Start Date
2023-12-22
Trial ID
NCT06132035
Treatments Being Tested
The purpose of this prospective interventional study is to assess whether a...
Status
Withdrawn
Location
Duke Eye Center
Start Date
2016-01
Trial ID
NCT02457026
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of every 2 week ...
Status
Unknown
Location
Tennessee Retina
Start Date
2018-04
Trial ID
NCT03468296
Treatments Being Tested
Diabetic macular edema refers to swelling (fluid accumulation) in the cente...
Status
Completed
Location
St. Michael's Hospital Eye Clinic
Start Date
2015-08
Trial ID
NCT02441907
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye...
Status
Active Not Recruiting
Location
Barnet Dulaney Perkins Eye Center - Phoenix
Start Date
2024-01-09
Trial ID
NCT06116916
Treatments Being Tested
Generally, DM is caused by insufficient insulin secretion in the body; howe...
Status
Not Yet Recruiting
Location
faculty of medicine, Tanta University
Start Date
2025-10-19
Trial ID
NCT06879301
Treatments Being Tested
The purpose of this study is to demonstrate how well aflibercept works in b...
Status
Completed
Location
Many Locations
Start Date
2019-09-25
Trial ID
NCT04004208
Treatments Being Tested
To determine whether a combination of intravitreal aflibercept and pranopro...
Status
Completed
Location
Multiple Locations
Start Date
2016-01
Trial ID
NCT03355638
Treatments Being Tested